98%
921
2 minutes
20
Background: Changes in rates of death due to pneumococcus during the COVID-19 pandemic period from 2020 to 2022 are not well understood.
Methods: We obtained vital statistics data for the United States (National Center for Health Statistics), including age, sex, race/ethnicity, cause of death (ICD-10), 2014-2022. Generalized linear models were fit to the period from January 2014-February 2020 and extrapolated to March 2020-December 2022 to generate an expected number of pneumococcal deaths and a 95% prediction interval.
Results: For most of 2020, pneumococcal deaths were not notably different from the pre-pandemic period and largely followed the typical seasonal pattern. However, at the end of 2020 and early 2021, when pneumococcal deaths would typically peak, the rates of death remained lower than normal and stayed lower than expected in the spring of 2021. Starting around mid-2021, there was a notable spike above baseline that coincided with the Delta wave of COVID-19. The 2021 winter - 2022 spring peak followed the pre-pandemic trend. Some of the changes could be attributed to changes in the seasonality of respiratory viruses that interact with pneumococcus.
Conclusion: Pneumococcal mortality patterns changed notably after the onset of the COVID-19 pandemic. Our findings highlighted the influence of respiratory viruses on the development and severity of pneumococcal disease.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.ijid.2025.108020 | DOI Listing |
Math Biosci Eng
July 2025
Department of Mathematics and Applied Mathematics, University of the Western Cape, Private Bag X17, Bellville 7535, South Africa.
In this paper, we present a deterministic model for the population dynamics of HIV/AIDS, wherein some individuals at the severe symptomatic phase of HIV develop serious opportunistic infections (OIs) such cryptococcal, tuberculous, pneumococcal, and other bacterial meningitis due to an inappropriate treatment or lack of counseling. OIs are responsible for significant mortality and disability on individuals with HIV in many countries. Cryptococcal meningitis (CM) is among frequent OIs responsible for significant mortality and disability of individuals with HIV in limited resource settings.
View Article and Find Full Text PDFBMC Public Health
September 2025
Universidad Nacional de Colombia, Bogotá, Colombia.
Background: The 10-valent pneumococcal conjugate vaccine (PCV10) has been offered to all infants through Colombia’s National Immunization Program (NIP) since 2012, with catch-up vaccination until age 5. However, pneumococcal vaccination is not currently included in the NIP for other age groups, such as those ≥ 5 years with medical conditions or older adults. This study assessed the pediatric PCV10 effect on pneumonia mortality rate (MR) trends across different age groups from 2006 to 2019.
View Article and Find Full Text PDFInt J Infect Dis
August 2025
Department of Epidemiology of Microbial Diseases, Yale School of Public Health. Electronic address:
Background: Changes in rates of death due to pneumococcus during the COVID-19 pandemic period from 2020 to 2022 are not well understood.
Methods: We obtained vital statistics data for the United States (National Center for Health Statistics), including age, sex, race/ethnicity, cause of death (ICD-10), 2014-2022. Generalized linear models were fit to the period from January 2014-February 2020 and extrapolated to March 2020-December 2022 to generate an expected number of pneumococcal deaths and a 95% prediction interval.
JAMA Netw Open
August 2025
Department of Paediatrics, Willem-Alexander Children's Hospital, Leiden University Medical Center, Leiden, the Netherlands.
Importance: An increase in pediatric cases of invasive group A streptococcus (iGAS) disease was noted in the Netherlands starting in early 2022. GAS disease can range from mild to life-threatening invasive infections. Clinical and public health decisions rely on timely and detailed reporting of clinical data.
View Article and Find Full Text PDFInfection
August 2025
Institute for Medical Informatics, Statistics, and Epidemiology (IMISE), University of Leipzig, Leipzig, Germany.
Background: COVID-19 continuously causes severe disease conditions and significant mortality. We evaluate whether easily accessible biomarkers can improve risk prediction of severe disease outcomes.
Methods: Our study analysed 426 COVID-19 patients collected by German CAPNETZ and PROGRESS study groups between 2020 and 2021.